title: Increased beam attenuation and surface dose by different couch inserts of treatment tables used in megavoltage radiotherapy.
abstract: The use of solid carbon fiber table materials in radiotherapy has become more common with the implementation of image-guided radiotherapy (IGRT), since the solid materials give less imaging artifacts than the so-called tennis racket couchtops. The downside of the solid carbon fiber couch inserts is that they increase the beam attenuation, resulting in increased surface doses and inaccuracies in determine the dose in the patient. The purpose of this study was to evaluate the interaction of 6 and 15 MV photons with eight different couch inserts. The presented results enable direct comparison of the attenuation properties of the studied couchtops. With a direct posterior beam the maximum attenuations reach 3.6% and 2.4% with 6 and 15 MV, respectively. The measured maximum attenuation by a couchtop with an oblique gantry angle was 10.8% and 7.4% at 6 and 15 MV energies, respectively. The skin-sparing effect was decreased substantially with every couchtop. The highest increases in surface doses were recorded to be four- and threefold, as compared to the direct posterior open field surface doses of 6 and 15 MV, respectively. In conclusion, the carbon fiber tabletops decrease the skin-sparing effect of megavoltage photon energies. The increased beam attenuation and skin doses should be taken into account in the process of treatment planning.
authors.affiliation: Department of Oncology and Radiotherapy, Turku University Hospital, Finland. jan.seppala@kuh.fi
authors.forename: Jan K H
authors.initials: JK
authors.lastname: Seppälä
authors.forename: Jarmo A J
authors.initials: JA
authors.lastname: Kulmala
mesh_terms: D002244:Carbon / Q000737:chemistry; D000077482:Carbon Fiber; D004867:Equipment Design; D019047:Phantoms, Imaging; D011879:Radiotherapy Dosage; D061089:Radiotherapy, Image-Guided / Q000295:instrumentation / Q000379:methods*
chemical_list: D000077482:Carbon Fiber; D002244:Carbon
references.citation: Radiother Oncol. 1998 Jun;47(3):249-54
references.pmid: 9681887
references.citation: Med Phys. 2008 Nov;35(11):4982-8
references.pmid: 19070232
references.citation: Appl Radiat Isot. 2008 Oct;66(10):1438-42
references.pmid: 18434173
references.citation: Med Dosim. 2001 Fall;26(3):251-4
references.pmid: 11704460
references.citation: Phys Med Biol. 2007 Oct 21;52(20):N485-92
references.pmid: 17921572
references.citation: Radiother Oncol. 2000 May;55(2):187-90
references.pmid: 10799731
references.citation: Med Dosim. 2009 Fall;34(3):228-32
references.pmid: 19647634
references.citation: Med Phys. 2005 Feb;32(2):483-7
references.pmid: 15789595
references.citation: Med Phys. 1990 Jan-Feb;17(1):17-26
references.pmid: 2106611
references.citation: Radiother Oncol. 2005 May;75(2):227-36
references.pmid: 15922469
references.citation: J Appl Clin Med Phys. 2009 Jun 02;10(3):16-27
references.pmid: 19692980
references.citation: Int J Radiat Oncol Biol Phys. 2008 Dec 1;72(5):1283-6
references.pmid: 19028267
references.citation: Phys Med Biol. 2009 May 7;54(9):N157-66
references.pmid: 19351984
references.citation: Phys Med Biol. 1998 May;43(5):1359-66
references.pmid: 9623664
references.citation: J Appl Clin Med Phys. 2006 Aug 24;7(3):21-7
references.pmid: 17533341
references.citation: Strahlenther Onkol. 2007 Jan;183(1):43-8
references.pmid: 17225945
references.citation: Med Phys. 2010 Jan;37(1):322-8
references.pmid: 20175495
references.citation: Radiother Oncol. 1997 Dec;45(3):275-7
references.pmid: 9426122
references.citation: Radiother Oncol. 2008 Oct;89(1):114-22
references.pmid: 18692264